N
Nicholas A. Shackel
Researcher at University of New South Wales
Publications - 133
Citations - 4129
Nicholas A. Shackel is an academic researcher from University of New South Wales. The author has contributed to research in topics: Hepatitis C & Cirrhosis. The author has an hindex of 31, co-authored 130 publications receiving 3473 citations. Previous affiliations of Nicholas A. Shackel include Duke University & Centenary Institute.
Papers
More filters
Journal ArticleDOI
Real‐time reverse transcriptase–polymerase chain reaction (RT–PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I
Jianlin Yin,Nicholas A. Shackel,Amany Zekry,P H McGuinness,Craig Richards,Karien Van Der Putten,Geoffrey W. McCaughan,Josette Eris,G. Alex Bishop +8 more
TL;DR: Real‐time quantitative reverse transcriptase–polymerase chain reaction (RT–PCR) is the method of choice for rapid and reproducible measurements of cytokine or growth factor expression in small samples, but in the authors' hands it did not equal the reproducible sensitivity and specificity of fluorogenic probes.
Journal ArticleDOI
HBV DNA Integration: Molecular Mechanisms and Clinical Implications
TL;DR: HBV DNA integration is likely to influence HBV replication, persistence, and pathogenesis, and so deserves greater attention in future studies.
Journal ArticleDOI
Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo.
Kathryn Williams,Kathryn Williams,Nicholas A. Shackel,Nicholas A. Shackel,Mark D. Gorrell,Mark D. Gorrell,Susan V. McLennan,Susan V. McLennan,Stephen M. Twigg,Stephen M. Twigg +9 more
TL;DR: The pathogenic links between NAFLD and diabetes are examined by exploring the epidemiological evidence in humans and also through newer animal models, and the potential role of preventive and therapeutic approaches in the setting of diabetes is examined.
Journal ArticleDOI
Insights into the Pathobiology of Hepatitis C Virus-Associated Cirrhosis : Analysis of Intrahepatic Differential Gene Expression
Nicholas A. Shackel,P H McGuinness,Catherine A. Abbott,Mark D. Gorrell,Mark D. Gorrell,Geoffrey W. McCaughan,Geoffrey W. McCaughan +6 more
TL;DR: HCV-associated cirrhosis was characterized by a proinflammatory, profibrotic, and proapoptotic gene expression profile.
Journal ArticleDOI
Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapy.
Silvana Gaudieri,Andri Rauch,Andri Rauch,Katja Pfafferott,Eleanor Barnes,Wendy Cheng,Geoff McCaughan,Nicholas A. Shackel,Gary P. Jeffrey,Lindsay Mollison,Ross I. Baker,Hansjakob Furrer,Huldrych F. Günthard,Elizabeth Freitas,Isla Humphreys,Paul Klenerman,Simon Mallal,Ian James,Stuart K. Roberts,David Nolan,Michaela Lucas,Michaela Lucas +21 more
TL;DR: Drug and host immune responses are likely to provide powerful selection forces that shape HCV genetic diversity and replication dynamics, and considered in terms of drug resistance as well as host “immune resistance” in the STAT‐C treatment era could provide important information toward an optimized and individualized therapy for chronic hepatitis C.